Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Public Health|April 6, 2007
Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, BrazilMaricea Engel, Fernanda M Malta, Michele M S Gomes, et al.
Medical Microbiology and Immunology|August 15, 2015
Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3Ketti G Oliveira, Fernanda M Malta, Ana C S S Nastri, et al.
Journal of Medical Virology|May 26, 2020
AIDS incidence and survival in a hospital-based cohort of HIV-positive patients from São Paulo, Brazil: The role of IFN-λ4 polymorphismsGabriela da Silva Prates, Fernanda M Malta, Fernanda de Toledo Gonçalves, et al.
Annals of Hepatology|May 6, 2019
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed populationDaniel F Mazo, Fernanda M Malta, Jose Tadeu Stefano, et al.
Molecular Diagnosis & Therapy|June 24, 2018
Molecular and Immnune Diagnosis: Further Testing for Human StrongyloidiasisLarissa R Bosqui, Priscilla D Marques, Gessica B de Melo, et al.
Virus Research|November 14, 2017
Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjectsTatiane Assone, Fernanda M Malta, Sonia Bakkour, et al.
Journal of Medical Virology|July 13, 2017
Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patientsGaspar Lisboa Neto, Fernanda M Malta, Michele S Gomes-Gouvêa, et al.
Parasite Epidemiology and Control|December 31, 2019
Subtypes of Blastocystis sp. isolated in fecal samples from transplant candidates in São Paulo, BrazilMaria do Rosário A Silva, Gessica B Melo, Fernanda M Malta, et al.
BMC Gastroenterology|February 24, 2021
The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis CArthur Ivan N Oliveira, Fernanda M Malta, Patricia Momoyo Y Zitelli, et al.
Antiviral Therapy|October 4, 2014
Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfectionGaspar Lisboa-Neto, Caroline F Noble, João R Rebello Pinho, et al.
Pageof 2